
Market Close: Stocks Higher, Dow Hit New Intraday High, FDA Questions Novo Nordisk TV Ad Claims About Weight Loss Pill 2/9/26
CNBC Business News Update
00:00
FDA Flags Novo Nordisk Ad Claims
Jessica summarizes Bloomberg reporting that the FDA says Wagobi ads may overstate weight-loss benefits versus other treatments.
Play episode from 01:06
Transcript


